Journal of Gastrointestinal & Digestive System
Open Access

Abstract

Introduction: The WHO recorded that nearly two third of people in Iraq were overweight and obese; the placement of intra-gastric balloon (IGB) constitutes a short term, effective, nonsurgical intervention to lose weight. Objective: This study was performed to assess the safety and effectiveness (success or satisfaction) of 566 patients with IGB to treat obesity. Methods: This was a prospective clinical case series study which includes 566 patients for whom IGB (520 Medsil, 35S patz3, 8 Endalis and 3 Heliosphere) introduced, the safety assessed for all while the effectiveness assessed for 320 patients. Results: 320 patients (245 females and 75 males), their age 14-64 (mean 35 years) underwent the procedure and their balloon removed after 4-13 months average 7 months (for the recommended 6 months balloon) and 3-16 months (spatz3). The average weight obtained was 132 (76-209 kg). The patient lost 3-76 (average 22 kg which was equal to 4.3-114.2 (average31) percent of excess weight. Their BMI reduced was 0.6-21 (average 8.5 kg/m2). Their associated comorbidity improved after weight loss and the quality of life improved in 76% of patients depending on bariatric analysis and reporting outcome system (BAROS). We recorded 2 cases of mortality from 566 (0.35%) in extreme obesity, these mortality were not related to balloon itself but to the associated morbidities. Conclusions: Obese and morbidly obese patients can reduce their weight effectively by the simple procedure of IGB and although this procedure cannot be regarded as successful (31% EWL), but many patient are satisfied with it and their quality of life improved (satisfied) with decrease in their morbidity.

Biography

Email: muthanna_asaad@yahoo.com